Hong Kong Life Sciences and Technologies Group Limited expected that the Group will record a profit for the three months ended 30 June 2018 as compared to the loss of approximately HKD 1.4 million for the three months ended 30 June 2017. The profit for the First Quarterly Results 2018 was mainly attributable to the reversal of certain impairment loss on loan interest receivables which recognised in the financial year ended 31 March 2018 of approximately HKD 5.5 million.